Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
9(50%)
Results Posted
60%(3 trials)

Phase Distribution

Ph early_phase_1
1
6%
Ph phase_1
4
22%
Ph not_applicable
7
39%
Ph phase_2
6
33%

Phase Distribution

5

Early Stage

6

Mid Stage

0

Late Stage

Phase Distribution18 total trials
Early Phase 1First-in-human
1(5.6%)
Phase 1Safety & dosage
4(22.2%)
Phase 2Efficacy & side effects
6(33.3%)
N/ANon-phased studies
7(38.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

9

trials recruiting

Total Trials

18

all time

Status Distribution
Active(13)
Completed(5)

Detailed Status

Recruiting8
Completed5
Not yet recruiting4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
9
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (5.6%)
Phase 14 (22.2%)
Phase 26 (33.3%)
N/A7 (38.9%)

Trials by Status

recruiting844%
active_not_recruiting16%
completed528%
not_yet_recruiting422%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT07693543Phase 2

Nicotinamide Riboside Supplementation in Chronic Kidney Disease

Not Yet Recruiting
NCT07703137Not Applicable

NAD Supplementation in Parkinson's Disease

Not Yet Recruiting
NCT04332341Early Phase 1

Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation

Recruiting
NCT04614714Phase 2

Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants

Not Yet Recruiting
NCT07563322Not Applicable

Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension

Recruiting
NCT07344636Not Applicable

Effects of NR Supplementation on Metabolic Flexibility in Zone 2 Training

Recruiting
NCT07284225Not Applicable

Acute Effects of Nicotinamide Riboside on Polysomnography-Measured Sleep Structure in Healthy Adults

Not Yet Recruiting
NCT06971224Phase 2

NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals

Recruiting
NCT06280482Phase 1

Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS)

Recruiting
NCT06425042Not Applicable

Nicotinamide Riboside Supplementation and Exercise Training to Promote Healthy Longevity

Recruiting
NCT05517122Not Applicable

Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults

Completed
NCT06853743Phase 2

The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease

Recruiting
NCT05703074Phase 2

Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid

Active Not Recruiting
NCT06208527Phase 2

The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging

Recruiting
NCT05698771Phase 1

NAD-brain: a Pharmacokinetic Study of NAD Replenishment Therapy

Completed
NCT04112043Phase 1

Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial)

Completed
NCT03789175Phase 1

Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

Completed
NCT02812238Not Applicable

Study to Evaluate the Effect of Nicotinamide Riboside on Immunity

Completed

All 18 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
18